BIOREGENX, INC. (BRGX) › Cash & EquivalentsBIOREGENX, INC. (BRGX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $125.4K2024: $58.4K$58.4K2023Cash & Equivalents (USD)2024Fiscal YearCash & EquivalentsChange YoY2024$58.4K-53.4%2023$125.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share